The latest health news
Harvard scientist George Church, a pioneer of both DNA sequencing and gene editing, has been talking in the press for more than a decade about the possibility of bringing the …
Read More
Biogen CEO Michel Vounatsos admitted Thursday that the launch of Aduhelm, the company’s intensely scrutinized treatment for Alzheimer’s disease, has been “slower than we anticipated,” which he blamed in part …
Read More
Moderna will turn to a biotech startup, National Resilience, to manufacture additional doses of its Covid-19 vaccine. Moderna had previously said it would manufacture 800 million to 1 billion doses …
Read More
French drug maker Sanofi said Wednesday that it will acquire Kadmon Pharmaceuticals for $1.9 billion, bolstering its transplant medicines business with a newly approved treatment for graft-versus-host disease. The all-cash …
Read More
Illumina, the DNA sequencing giant, said Wednesday it has closed its $8 billion purchase of Grail, a cancer diagnostics firm, even though the U.S. Federal Trade Commission has sued to …
Read More
The CEO of the SENS Research Foundation left his job and seat on the organization’s board in July amid an investigation into sexual harassment allegations against the anti-aging nonprofit’s high-profile …
Read More
Editor’s note: A recording of the event is embedded below. The first gene therapies have reached the market, and patients. But for such treatments to reach their potential, more advances …
Read More
Aubrey de Grey, the jet-setting gerontologist who co-founded the SENS Research Foundation to discover ways to reverse the ravages of aging, has been placed on leave by the foundation after …
Read More
Biogen on Thursday mounted a vigorous defense of its controversial Alzheimer’s drug, Aduhelm, with the company’s head of research and development releasing an open letter to the Alzheimer’s community that …
Read More